Friday, November 27, 2015

Smoking-gum makers Glaxo, J&J lobby against e-cig comptetitors

But no one fights tobacco-pesticide profiteers, reader complains

Smoking-gum makers Glaxo, J&J lobby against e-cig comptetitors

In this undated image from video provided by Resound Marketing in August 2013, Jenny McCarthy uses a blu eCig in a television advertisement. (AP Photo / Resound Marketing)
In this undated image from video provided by Resound Marketing in August 2013, Jenny McCarthy uses a blu eCig in a television advertisement. (AP Photo / Resound Marketing)

GlaxoSmithKline Plc wants an advertising ban and strict European regulation of electronic cigarettes, which don't contain tobacco, but which do "compete with its Nicorette gum and other smoking cessation products," Bloomberg reports here, citing internal company emails.

Glaxo, which sells Nicorette in the U.S., is lobbying Europe to class e-cigarettes as "medicines," which claim European sales of $7 billion a year. The European parliament is supposed to vote on the proposal next week.  

J&J, which "markets the Nicorette line of products in all markets outside the U.S., is also 'strongly in favor of' regulating all non-tobacco nicotine products, including e-cigarettes, as medicines, Caroline Almeida, a spokeswoman for the New Brunswick, New Jersey-based company," told Bloomberg.

Separately, reader J. Jonik says we ought to reference Philadelphia-based FMC Corp.'s role in the tobacco business more when we write about the chemical maker and its planned 47-story headquarters. "FMC is part of Big Cig, as is Bayer (a "health products" company?), Dow-Rohm-Haas, DuPont and others with which local officials may have economic links," Jonik writes me in a note.

In my recent FMC update, Jonik adds, "you did mention "farm pesticides", but what's wrong with adding '...including tobacco pesticides... FMC Corp. and the others evaded paying" the industrywide "Tobacco Settlements" that Pennsylvania and other states collected from the big cigarette makers, he added. Jonik notes a 2003 General Accountabilty Office report stressing the pesticide industry's deep profits from tobacco has been followed by general U.S. Government silence on the industry's continuing role in smoking.

We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog

PhillyDeals posts interviews, drafts and updates that Joseph N. DiStefano writes alongside his Sunday and Monday columns and ongoing articles about Philadelphia-area business.

DiStefano studied economics, history and a little engineering at Penn. He taught writing and research at St. Joe’s. He has written for the Inquirer since 1989, except when he left a few times to work at Bloomberg and elsewhere. He wrote the book Comcasted, and raised six kids with his wife, who is a saint.

Reach Joseph N. at, 215.854.5194, @PhillyJoeD. Read his blog posts at and his Inquirer columns at Bloomberg posts his items at NH BLG_PHILLYDEAL.

Reach Joseph at or 215 854 5194.

Joseph DiStefano
Also on
letter icon Newsletter